Search

everythinglearnresearchcommunity

for

Search:↓

Lygodii Spora extract may help treat hair loss by blocking a hair loss-related enzyme and promoting hair growth.

Topical finasteride and flutamide reduce gland size and enzyme activity, with flutamide being more potent, potentially treating acne, seborrhea, hirsutism, and androgenic alopecia.

A patient with a larger than usual genetic mutation had a broader range of symptoms for a muscle disease.

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

The document reports the first Brazilian case of a girl with Becker nevus syndrome, characterized by skin changes, breast underdevelopment, and scoliosis.

Hormonal therapies help treat female hair loss, but results are slow and vary.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Obese women had more testosterone and less acne, but similar hair growth compared to non-obese women.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Treat pattern hair loss with finasteride and topical minoxidil.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Finasteride may cause kidney damage.

Men using hair loss drugs like finasteride may experience sexual side effects like erectile dysfunction, but it's unclear who will be affected and when. Treating depression and sexual symptoms is suggested, as these men often have higher rates of both. More research is needed to understand why these side effects occur.

Scientists have found specific genes linked to different hair loss conditions, which could lead to new treatments.

Increased PPARGC1α relates to hair thinning in common baldness.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Phyllanthus urinaria extract may help treat hair loss by blocking a hair-related enzyme.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

Finasteride negatively affects fish reproduction and gonadal development.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Androgens contribute to common male hair loss; more research needed for hair growth medication.

Two women with very high androgen levels had only slight skin issues, one due to a non-classical adrenal disorder and the other due to an adrenal tumor.

Male yak hair growth is influenced by DHT synthesis, which is promoted by 5α-red1 and AR during growth phases, while E2 may inhibit growth through ERα.

Men with less sun-sensitive skin have lower PSA levels, while men with more sun-sensitive skin have higher PSA levels.